Zoetis (ZTS) Common Equity (2012 - 2026)

Zoetis (ZTS) has reported Common Equity for 15 consecutive years, with $3.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 38.98% year-over-year to $3.1 billion in Q2 2026; TTM through Jun 2026 was $3.1 billion, a 38.98% decrease from a year earlier, with the FY2025 full-year figure at $3.4 billion, down 43.08% from the prior year.
• Common Equity was $3.1 billion for Q2 2026 at Zoetis, down from $3.2 billion in the prior quarter.
• Over five years, Common Equity peaked at $6.0 billion in Q1 2025 and troughed at $3.1 billion in Q2 2026.
• A 5-year average of $4.7 billion and a median of $4.8 billion in 2022 frame the typical range for Common Equity.
• Across the five-year window, Common Equity gained 18.76% in 2025 and slumped 46.12% in 2026, its largest moves.
• Over 5 years, Common Equity stood at $4.4 billion in 2022, then grew by 13.35% to $5.0 billion in 2023, then slipped by 2.95% to $4.8 billion in 2024, then declined by 29.5% to $3.4 billion in 2025, then dropped by 7.82% to $3.1 billion in 2026.
• The last three Common Equity figures came in at $3.1 billion (Q2 2026), $3.2 billion (Q1 2026), and $3.4 billion (Q4 2025), per Business Quant data.